[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356830-105":59,"doc-detail-356830-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","clinicopathological-and-molecular-characterization-of-tumor-associated-macrophages-in-sporadic-and-xeroderma-pigmentosum-related-cutaneous-melanoma","Clinicopathological and molecular characterization of tumor-associated macrophages in sporadic and Xeroderma Pigmentosum-related cutaneous melanoma","","Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder caused by defects in nucleotide excision repair (NER), predisposing patients to skin cancers, including melanoma. This study examines how the melanoma immune microenvironment, enriched with macrophages, differs in XP. Serum cytokine profiling and macrophage-marker assessment (CD68, CD163, and iNOS) show reduced inflammatory mediator levels in XP-melanoma and links between IL-33/iNOS and inflammatory infiltrate density. In vitro, IL-33 and pro-inflammatory macrophage-conditioned media suppress G361 melanoma proliferation, supporting macrophage biomarkers and potential local IL-33 delivery as therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinicopathological-and-molecular-characterization-of-tumor-associated-macrophages-in-sporadic-and-xeroderma-pigmentosum-related-cutaneous-melanoma/356830/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinicopathological-and-molecular-characterization-of-tumor-associated-macrophages-in-sporadic-and-xeroderma-pigmentosum-related-cutaneous-melanoma/356830.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What genetic defect underlies xeroderma pigmentosum and why does it matter for melanoma?","Question",{"text":112,"@type":113},"Xeroderma pigmentosum results from defects in the nucleotide excision repair (NER) pathway. This predisposes individuals to skin cancers, including melanoma.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which inflammatory and macrophage-related markers were found at reduced levels in XP-melanoma patients?",{"text":117,"@type":113},"XP patients showed significantly reduced levels of iNOS, MIP-1β, MCP-1, and IL-33, indicating impaired inflammatory and macrophage-mediated immune responses.",{"name":119,"@type":110,"acceptedAnswer":120},"How did IL-33 affect melanoma cells in vitro?",{"text":121,"@type":113},"Pro-inflammatory macrophage-conditioned media and exogenous IL-33 suppressed G361 tumor cell proliferation in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356830,1790385841,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Chikhaoui etal. BMC Cancer (2026) 26:650 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15966-8](https://doi.org/10.1186/s12885-026-15966-8)  \nRESEARCH Open Access  \nClinicopathological and molecular characterization of tumor-associated macrophages in sporadic and Xeroderma Pigmentosum-related cutaneous melanoma  \nAsma Chikhaoui1, Haifa Tounsi1, Imen Nabouli 1, Mariem Jones2, Rim Jenni1, Malika Ben Ahmed3, Chokri Naouali 1, Mohammed Zghal2, Hamida Turki4 and HoudaYacoub-Youssef1*  \nAbstract  \nBackground Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder, resulting from genetic defects in the nucleotide excision repair (NER) pathway. It predisposes individuals to skin cancers, including melanoma. The melanoma microenvironment is enriched with inflammatory mediators, particularly macrophages, which may serve as prognostic biomarkers or therapeutic targets. While inflammation is linked to melanoma outcomes, its role in carcinogenesis among XP patients remains poorly understood.  \nMethods We assessed the cytokine profiles in the sera of XP-melanoma patients, as well as the expression level of a pan-macrophage marker (CD68), M2-markers CD163, and M1-associated nitric oxide synthase (iNOS) expression. Results XP patients exhibited significantly reduced levels of iNOS, MIP-1β, MCP-1, and IL-33, indicating an impaired inflammatory and macrophage-mediated immune response. We also found that IL-33 and iNOS levels were positively correlated with the density of inflammatory infiltrates. Moreover, in vitro assays using G361 melanoma cells demonstrated that both pro-inflammatory macrophage-conditioned media and exogenous IL-33 suppressed tumor cell proliferation.  \nConclusion This study emphasizes the need for specific macrophage biomarkers and proposes local interleukin-33 delivery as a potential therapy for poorly infiltrated melanoma. This also suggests that NER-deficient patients may exhibit unique molecular profiles, warranting personalized treatment.  \nKeywords IL-33, Cutaneous malignant melanoma, Tumor-associated macrophage, Xeroderma Pigmentosum  \n*Correspondence:  \nHoudaYacoub-Youssef  \n[houda.yacoub@pasteur.utm.tn](houda.yacoub@pasteur.utm.tn)  \n1Laboratory of biomedical genomics and oncogenetics (LR16IPT05), Institut Pasteur de Tunis, Tunisia, University Tunis El-Manar, Tunis, Tunisia 2Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia 3Laboratory for research on the transmission, control and immunobiology of infections, LR16IPT02, Institut Pasteur de Tunis, University Tunis ElManar Tunis, Unisia, Tunis, Tunisia  \n4Department of Dermatology, Hedi Chaker Hospital, University of Sfax, Sfax, Tunisia  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nChikhaoui et al. BMC Cancer (2026) 26:650  \nBackground  \nThe global incidence of skin cancers has risen markedly over the last decades [1]. Although, cutaneous melanoma remains ","cbCaicDC2jckK7tE","https://ap.wps.com/l/cbCaicDC2jckK7tE","pdf",3656763,14,"English","# Abstract\n# Background\n# Methods and Results\n# Conclusion","[{\"question\":\"What genetic defect underlies xeroderma pigmentosum and why does it matter for melanoma?\",\"answer\":\"Xeroderma pigmentosum results from defects in the nucleotide excision repair (NER) pathway. This predisposes individuals to skin cancers, including melanoma.\"},{\"question\":\"Which inflammatory and macrophage-related markers were found at reduced levels in XP-melanoma patients?\",\"answer\":\"XP patients showed significantly reduced levels of iNOS, MIP-1β, MCP-1, and IL-33, indicating impaired inflammatory and macrophage-mediated immune responses.\"},{\"question\":\"How did IL-33 affect melanoma cells in vitro?\",\"answer\":\"Pro-inflammatory macrophage-conditioned media and exogenous IL-33 suppressed G361 tumor cell proliferation in vitro.\"}]","Clinicopathological and molecular characterization of tumor-associated macrophages in sporadic and Xeroderma Pigmentosum-related cutaneous melanoma | PDF",1790127542,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ee8a6e284bdd5e1e4975363fa013147d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6528d80b70c61f1fc3319ae6784b30dd.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2ee95f58411ba91a34214da0245ab0c.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16d5378a80094708e96da9e632ee16c1.webp",980,1306]